OPPOSE THE FRAUD
The FDA has scheduled meetings to consider authorizing the use of Pfizer and Moderna injections in children and infants as young as 6 months. THIS MUST BE STOPPED.
Scroll down the page in order to REVIEW SAMPLE EMAILS, make phone calls, submit comments and help spread the word.
PLEASE SHARE THIS LINK WITH EVERYONE YOU KNOW ASAP:
Watch the videos below…
Click on each of the images below and take as many of the following actions as you possibly can !
The following groups have set up systems to help people send automated emails to various politicians and the members of the Vaccine Advisory Committee.
The text below is the email that is sent through the Children’s Health Defense website:
We are counting on you to safeguard the future of our children. The stakes couldn't be higher. Now is NOT the time to lower the bar (by removing the 50% minimal efficacy standard) to approve Emergency Use Authorizations (EUA) for shots that provide no significant health benefit and may pose serious risks to our children.
The COVID vaccination program has been a disappointment across the board, but our children stand to gain virtually nothing and risk losing their health and potentially their lives to COVID shots. While the “protection” they offer is both substandard and fleeting, their potential harm may very well be permanent and life-altering.
As you review Emergency Use Authorization applications to approve Moderna and Pfizer COVID shots for children as young as 6 months old, please consider the following:
There is no COVID emergency for children under five years old.
Children under 18 with no comorbidities have virtually no risk of death. They have a 99.95% recovery rate and the vast majority of children have minimal symptoms. A study published in Nature described how children mount effective, robust and sustained immune responses to COVID. And the CDC’s own data show that at least 74.2% of children already have this superior natural immunity.
mRNA shots offer little in the way of protection.
There is no clinically significant health benefit from the shots. Moderna’s own press release acknowledges that “the absence of any severe disease, hospitalization or death in the study precludes the assessment of vaccine efficacy against these endpoints.” Preliminary data showed the shots were only about 44% effective at preventing symptomatic infection in children 6 months to 2 years old, and 37% effective in children ages 2 to 5 — both below the 50% level that regulators had generally called the minimum level for EUA approval in 2020. In New York, officials observed that Pfizer’s efficacy against Omicron plummeted from 68% to 12% after 7 weeks in children ages 5 to 11.
Injuries from COVID shots in children are catastrophic.
Vaccinated children face a substantial risk of myocarditis. Moderna’s EUA application, originally filed in June 2021, has already been held up because of a clear safety signal for myocarditis, which has already prompted a number of European countries to prohibit its use in young people. Additionally, the Vaccine Adverse Events Reporting System (VAERS) already has over 48,500 reports of adverse events in children, including 112 deaths (as of May 20, 2022) and a growing number of reports of encephalopathies, clotting issues, diabetes and neurological issues in children following COVID shots.
Our children deserve better. Pharmaceutical products that cannot meet standard efficacy thresholds and have been linked to serious harm (and in some cases death) in thousands of children, are unnecessary for an illness that healthy children can easily recover.
I strongly urge you to reject the Pfizer and Moderna EUA applications for children, and as elected officials, ensure our government agencies are following the science.
Contact the people listed below and share your personalized opinion with them A.S.A.P. Please feel free to use your own words. The text below are merely a suggested starting point.
Follow the Science, Children DO NOT need the COVID vaccine!
To the members of the advisory committees and the employees of the FDA and the CDC:
DON’T YOU DARE ADVISE THE FDA OR CDC TO APPROVE THESE INJECTIONS!
There is absolutely NO VALID REASON to approve either the Pfizer-BioNTech or Moderna injections for use in infants and children from 6 months to 5-6 years of age.
Children from 6 months to 6 years old do not die from COVID-19. Young children and babies DO NOT need the COVID shots!
Babies and young children are NOT at risk of serious complications or death from COVID.
However, they ARE at risk from injury and even death from COVID vaccines.
Subjecting babies and children to experimental injections with extraordinarily high rates of adverse events such as cardiomyopathy, vasculopathies, neuropathies and more, against a "disease" that poses virtually no risk to the proposed recipients is horrifyingly bad public policy and constitutes willfully negligent medicine.
World-wide experience with these deeply flawed injections clearly shows that they do not prevent transmission or infection. In fact, these shots predispose the recipients to clinical illness.
Cataclysmic immediate and medium-term damage is a frequent consequence of these injections in persons with mature immune systems.
Authorizing their use in babies and toddlers is unconscionable, especially given that the threat due to COVID and its variants is virtually non-existent.
Abundant evidence shows that COVID poses nearly zero risk to this age group:
Data from England and Wales, published by the UK Office of National Statistics on January 17, 2022, revealed that throughout 2020 and 2021, only one child under the age of 5, without comorbidities, died from COVID in the two countries, whose total population is 60 million.
- A large study conducted in Germany showed zero deaths for children 5-11 and a case fatality rate of three out of a million in children without comorbidities.
- Another study in Nature from April 2021, suggests children’s bodies clear the virus more easily than adults.
- A study published in December in Nature demonstrated how children efficiently mount effective, robust and sustained immune responses to COVID.
WE ARE ALL VERY MUCH AWARE that the risk of serious disease or death due to COVID-19 is practically ZERO in children from 6 months to 6 years of age (and up).
To recommend the authorization of the use of these products when they can only cause harm would be a blatantly unscientific and unethical act on your part.
Use of proxy markers to imitate effectiveness rather than actual disease outcomes is not a valid reason to authorize these products.
The trials are underpowered and cannot possibly identify rare but serious risks.
To even consider further exposure to this very risky injection among the infants and young children of this nation is unconscionable. I urge you to do everything in your power to halt any further discussion of granting EUA status to this age group.
Please be advised that your actions during the upcoming advisory committee meetings will be viewed by millions of Americans, and also by millions of additional concerned people around the world.
YOU KNOW THIS, AND WE KNOW THAT YOU KNOW THIS.
The job of the FDA is to protect us, not to pose avoidable and unnecessary threats to us for reasons having nothing at all to do with our health.
If you vote to authorize for emergency use either the Pfizer-BioNTech or Moderna injections for use during the upcoming meetings on June 14-15, 2022, HISTORY WILL HOLD YOU PERSONALLY RESPONSIBLE FOR HEINOUS CRIMES AGAINST HUMANITY.
Instead, I invite you to stand up against the forces of the medical, hospital, pharmaceutical, educational, industrial and media complex.
I invite you to look in the mirror and examine your heart and soul. I trust that you will find the inherent humanity that will guide you to make the right decision, which is clearly to reject the very notion of these injections.
I invite you to be courageous.
I will welcome you as a hero if only you will listen to the will of We the People and wisely reject the requests made by Pfizer-BioNTech and Moderna.
MAKE SOME PHONE CALLS
PUBLICLY AVAILABLE CONTACT INFO (PHONE NUMBERS):
All of the contact information below is readily available at the link below…
Hayley Gans, M.D. Department of Pediatrics, Division of Pediatric Infectious Diseases Stanford University Medical Center, Stanford, CA 94305-5208 Fax: (650) 725-8040 Email: email@example.com PHONE: (650) 723-5682
Adam C.Berger, PhD 6705 Rockledge Drive, Suite 630 Bethesda, MD 20892 EMAIL: firstname.lastname@example.org PHONE: 301-827-9676
Archana Chatterjee, M.D., Ph.D. Dean Chicago Medical School 3333 Green Bay Road North Chicago, IL 60064 FAX: 847-578-3345 Email: Archana.Chatterjee@RosalindFranklin.edu PHONE: 847-578-3301
CAPT Amanda Cohn National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention 1600 Clifton Rd, Atlanta, GA 30333 MS C-09 E-mail: email@example.com PHONE: (404) 639-6039
Holly Janes, Ph.D. Fred Hutchinson Cancer Research Center Vaccine and Infectious Disease Division 1100 Fairview Avenue North, M2-C200 P.O. Box 19024 Seattle, Washington 98109 E-mail: firstname.lastname@example.org PHONE: 206-6676353
David Kim, MD CAPT, U.S. Public Health Service Vaccine Program Office of Infectious Disease and HIV/AIDS Policy Office of the Assistant Secretary for Health U.S. Department of Health and Human Services 330 C Street SW, Suite L600 Washington, DC 20024 Email email@example.com Main (202) 795-7697 PHONE (202) 795-7636
Jay M. Portnoy, MD Director, Division of Allergy, Asthma & Immunology Children’s Mercy Hospitals & Clinics 2401 Gillham Road Kansas City, MO 64108 EMAIL: firstname.lastname@example.org FAX: (816) 960-8888 PHONE: (816) 960-8885
Andrea (Andi) L. Shane, MD MPH MSc Emory University School of Medicine 2015 Uppergate Drive NE, Rm. 504A Atlanta, GA 30322 EMAIL: email@example.com FAX: 404-727-8249 MAIN: 404-727-5642 PHONE: 404-727-9880
Gregg C. Sylvester, MD, MPH Head of Medical Affairs for Seqirus 470 Burnt Mill Road Wilmington, DE 19807 EMAIL: firstname.lastname@example.org MOBILE: 302-272-0653
I have been unable to find contact information for the following VRBPAC members. Your help will be much appreciated. Post publicly available contact information ONLY in the comment section.
FDA Contact Information:
Prabhakara Atreya: 240-506-4946
Sussan Paydar: CBERVRBPAC@fda.hhs.gov
FDA Advisory Committee Information Line:
1-800-741-8138 or 301-443-0572
For press inquiries, please contact the Office of Media Affairs at email@example.com or 301-796-4540
Please watch these videos and take the appropriate actions…
Enough is Enough - Doctors Send Warning to Parents as FDA nears EUA of COVID Shots for Under 5
SCROLL DOWN TO WATCH LIVESTREAMS OR RECORDINGS OF FDA AND CDC MEETINGS
June 7, 2022 - VRBPAC meeting regarding Novavax
June 7, 2022 - Deadline for written comments to be made available to Committee that is meeting on June 14-15. (SUBMIT WRITTEN COMMENT HERE)
June 8, 2022 - Deadline to send email request to make oral comments during June 14-15 meeting (see details below)
June 13, 2022 - Deadline for comments to be considered by the FDA. (SUBMIT WRITTEN COMMENT HERE)
June 14, 2022 - VRBPAC meeting regarding Moderna (6-17 year olds)
June 15, 2022 - Pfizer-BioNTech and Moderna in babies
June 15, 2022 - Deadline for submitting request to provide oral public comment during June 17-18 ACIP meeting. (SUBMIT REQUEST FOR ORAL PUBLIC COMMENT HERE)
June 17-18, 2022 - ACIP meeting
June 22, 2022 - Deadline for written comments to be made available to Committee that is meeting on June 28, 2022
June 22-23, 2022 - ACIP meeting
June 27, 2022 - Deadline for comments to be considered by the FDA regarding the June 28 meeting.
June 28, 2022 - Bypassing studies for future injections
It appears that the FDA and the CDC are not even pretending to care about science anymore.
The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) wants to grant Emergency Use Authorization to Pfizer’s BioNTech and Moderna’s injectable bioweapons for babies aged 6 months and children up to 5 years old, despite the lack of evidence of safety and efficacy to support its use.
This may be yet another Fantastically Dumb Action by the FDA.
“If your blood is not boiling, it must be clotting.”
The Pfizer clinical trial in kids under 5 failed in December 2021.
Pfizer added a third dose and that trial also failed in February, which is why they withdrew their application on February 10, 2022.
Now Pfizer is describing a jerry-rigged trial of a third dose in 1,678 kids ages 6 months to four years old.
Pfizer has not disclosed how the kids were divided between the treatment and control group so it is impossible determine efficacy.
Out of that sample, 10 developed COVID-19 — although it is not clear how the 10 were distributed between the treatment and control group.
Pfizer is NOT looking at health outcomes in the real world (because there are none). Instead, all of their claims are based on measurements of antibodies in the blood.
The FDA’s Vaccines and Related Biological Products Advisory Committee unanimously acknowledged on April 6 that proxy measurements, such as antibody counts, DO NOT determine whether someone is immune to the virus or not.
The only reason Pfizer and the FDA are focused on antibodies in the blood is because the trial produced NO clinically significant health outcomes.
Pfizer also failed to describe the contents of the “placebo.”
The US Food and Drug Administration has clearly added a warning about the additional risks of myocarditis and pericarditis connected to the Pfizer-BioNTech Covid-19 injections.
Moderna’s injections have been reported to be 37-51% effective.
Moderna’s injections have NOT been approved in those who are under 18 years of age.
Moderna is NOT looking at health outcomes in the real world (because there are none). Instead, all of their claims are based on measurements of antibodies in the blood.
The US Food and Drug Administration has clearly added a warning about the additional risks of myocarditis and pericarditis connected to the Moderna Covid-19 injections.
The White House has just announced that they have purchased 10 million doses of Pfizer and Moderna COVID-19 mRNA vaccines that became available today for all 50 states to purchase in preparation for injecting babies and toddlers between the ages of 6 months and 5 years old within the next few weeks.
And since the FDA has not even conducted an advisory committee meeting yet, let alone issued emergency use authorizations for this age group, the purchase and distribution of these killer shots proves once again that the FDA just rubber stamps whatever the pharmaceutical industry wants.
FDA MEETING 1
WATCH THE MEETING ON TUESDAY JUNE 7, 2022:
The committee will meet in open session to discuss an Emergency Use Authorization (EUA) request by Novavax for a vaccine to prevent COVID-19 in individuals 18 years of age and older.
Prabhakara Atreya (240-506-4946) or Sussan Paydar: CBERVRBPAC@fda.hhs.gov
FDA Advisory Committee Information Line:
1-800-741-8138 (301-443-0572 in the Washington, DC area) Please call the Information Line for up-to-date information on this meeting.
FDA MEETING 2
WATCH THE MEETING ON TUESDAY JUNE 14, 2022:
The Docket Number is FDA-2022-N-0904
On June 14, 2022, under Topic 1, the committee will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age.
DOCUMENTS ARE NOT YET AVAILABLE
SUBMIT A PUBLIC COMMENT:
FOR FURTHER INFORMATION CONTACT: Prabhakara Atreya or Sussan Paydar, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Silver Spring, MD 20993-0002, 240-506-4946, or via email at CBERVRBPAC@fda.hhs.gov; or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area).
FDA MEETING 3
WATCH THE MEETING ON WEDNESDAY JUNE 15, 2022:
The Docket Number is FDA-2022-N-0904
On June 15, 2022, under Topic II, the committee will meet in open session to discuss
amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age
amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age.
INFORMATIONAL DOCUMENTS ARE NOT YET AVAILABLE
SUBMIT A WRITTEN PUBLIC COMMENT:
Comments received on or before June 7, 2022, will be provided to the committee. Comments received after June 7, 2022, and by June 13, 2022, will be taken into consideration by FDA.
Prabhakara Atreya or Sussan Paydar, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Silver Spring, MD 20993-0002, 240-506-4946, or via email at CBERVRBPAC@fda.hhs.gov; or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area).
The FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting, any background material will be made publicly available at the time of the advisory committee meeting, and additional materials will be posted on FDA's website after the meeting.
CDC MEETING 1
June 17, 2022: 10:00am – 3:30pm ET
June 18, 2022: 10:00am – 4:00pm ET
How to Submit a Written Public Comment
Any member of the public can submit a written public comment to ACIP. Written comments must be received by June 18, 2022, identified by Docket No. TBA using the Federal eRulemaking Portal. Follow the instructions for submitting comments. All submissions received must include the agency name and Docket Number.
All relevant comments received will be posted without change to
, including any personal information provided. For access to the docket or to read background documents or comments received, go to
How to Request to Make an Oral Public Comment
The June 17-18, 2022 ACIP meeting will be a virtual meeting and will include time for oral public comment for members of the public. All individuals interested in making an oral public comment are strongly encouraged to submit a request no later than 11:59 p.m., EST, June 15, 2022 as there will be no opportunity to register for oral public comment later than June 15th .
If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email June 16, 2022. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to 3 minutes, and each speaker may only speak once per meeting.
Request to Make an Oral Public Comment
The June 17-18, 2022 ACIP meeting will be a virtual meeting and will include time for oral public comment for members of the public.
If the number of people requesting to speak is greater than can be reasonably accommodated during the time scheduled for oral public comment, CDC may conduct a lottery to determine the speakers. CDC staff will notify individuals regarding their request to speak via email by June 16, 2022.
To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to 3 minutes, and each speaker may only speak once per meeting. Interested persons who are unable to make an oral public comment during this meeting are invited to submit a written comment.
Requests to Make an Oral Public Comment is Open
Oral Public Comment for June 17-18, 2022 Meeting
WATCH THE LIVESTREAM:
CDC MEETING 2
June 22, 2022: 10:00am – 5:00pm ET
June 23, 2022: 10:00am – 2:00pm ET
Matters to be considered: The agenda will include discussions on influenza vaccines; pneumococcal vaccine; human papillomavirus vaccine; measles, mumps, rubella (MMR) vaccine; respiratory syncytial virus vaccine; rotavirus vaccine; and Chikungunya vaccine. Recommendation votes on influenza vaccines, pneumococcal vaccine, and MMR vaccine are scheduled. No VFC votes are scheduled. Agenda items are subject to change as priorities dictate.
Written comments must be received on or before June 23, 2022.
Written Public Comment: The docket will be opened to receive written comments on May 10, 2022. Written comments must be received on or before June 23, 2022.
Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes, including all votes relevant to the ACIP's Affordable Care Act and Vaccines for Children program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making an oral public comment at the June 22-23, 2022, ACIP meeting must submit a request at https://www.cdc.gov/vaccines/acip/meetings/index.html no later than 11:59 p.m., EDT, June 13, 2022, according to the instructions provided.
FDA MEETING 4
WATCH THE MEETING ON TUESDAY JUNE 28, 2022:
The Docket Number is FDA-2022-N-0905
The committee will meet in open session to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified.
The purpose of the “Future Framework” is to rig the Covid-19 vaccine regulatory process in perpetuity in favor of the pharmaceutical industry. If this “Future Framework” is approved all future Covid-19 shots, regardless of the formulation, will automatically be deemed “safe and effective” without additional clinical trials because they are considered “biologically similar” to existing shots.
This is literally the worst idea in the history of public health.
If you change a single molecule of mRNA in these shots it will change health outcomes in ways that no one can anticipate. That necessarily requires new clinical trials — which is what the FDA is proposing to skip.
-Toby Rogers (see article below)
SUBMIT A PUBLIC COMMENT:
PROCEDURE: On June 28, 2022, from 8:30 a.m. to 5 p.m. ET, the meeting is open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. All electronic and written submissions submitted to the Docket (see ADDRESSES) on or before June 22, 2022, will be provided to the committee. Comments received after June 22, 2022, and by June 27, 2022, will be taken into consideration by FDA.
ORAL PRESENTATIONS: Oral presentations from the public will be scheduled between approximately 1:30 p.m. and 2:30 p.m. ET. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and email addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before 6 p.m. ET on June 21, 2022. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by June 23, 2022.
FDA Set to Authorize Experimental Pfizer, Moderna Shots for Youngest Children
Enough is Enough - Doctors Send Warning to Parents as FDA nears EUA of COVID Shots for Under 5
by James Roguski
The old system is crumbling, and we must build its replacement quickly.
If you are fed up with the government, hospital, medical, pharmaceutical, media, industrial complex and would like to help build a holistic alternative to the WHO, then feel free to contact me directly anytime.
James Roguski’s newsletter is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.